Over the past few years, the role of genomics in the clinic has expanded enormously. At the forefront is the Genomes2People (G2P) Research Program
Testing cancers for ‘addiction’ to a gene that boosts cell growth can pick out patients who may respond to a targeted drug under development
A survey of 12,562 social media users in 185 different countries has revealed widespread support and curiosity for therapeutic gene-editing
NEJM study is one of the first to show the life-changing benefits of genome-wide sequencing for children with certain kinds of intellectual disability
USC-led study reveals that melanoma patients with deficient or mutant copies of the gene are less protected from harmful ultraviolet rays
Women earn nearly one-third less than their male peers within a year of completing a PhD in science, technology, engineering or maths.
Nationwide Foundation Pediatric Innovation Fund bolsters recruitment of international genomics leaders to Nationwide Children’s Hospital
Nationwide Children’s Hospital has recruited Richard Wilson and Elaine Mardis, marking a transformational milestone for its genomics research program.
$10 million donation from Nationwide Foundation draws genomics luminaries to Nationwide Children’s Hospital
RetroSense Therapeutics begin clinical-safety trials for optogenetic vision disorder treatment, with potential to kick start new therapeutics
Lung cancer spread in mice is slowed by tampering with a specific protein pathway, suggesting a potential new therapy target for the disease
Using gene editing researchers have successfully excised a segment of HIV-1 DNA from the genomes of living animals.
A molecular pathway activated in the brain during fasting helps halt the spread of intestinal bacteria into the bloodstream